STORM THERAPEUTICS LIMITED

Active United Kingdom

Research and experimental development on biotechnology

38 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
S

STORM THERAPEUTICS LIMITED

Research and experimental development on biotechnology

Founded 21 Apr 2015 Active United Kingdom 38 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

ICENI THERAPEUTICS LIMITED 21 Apr 2015 — 24 Jun 2016
Accounts Due 30 Sept 2026 4 months remaining
Confirmation Submitted 1 May 2026 Next due 5 May 2027 12 months remaining
Net assets £-9M £11M 2024 year on year
Total assets £8M £4M 2024 year on year
Total Liabilities £17M £7M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for STORM THERAPEUTICS LIMITED (09553473), an active life sciences and medical technology company based in United Kingdom. Incorporated 21 Apr 2015. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2023–2024)

Cash in Bank

£4.20M

Decreased by £3.61M (-46%)

Net Assets

-£9.07M

Decreased by £11.00M (-570%)

Total Liabilities

£17.36M

Increased by £7.46M (+75%)

Turnover

£6.52M

Decreased by £808.06k (-11%)

Employees

38

Increased by 4 (+12%)

Debt Ratio

209%

Increased by 125 (+149%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 6
Grants 1

Investors (13)

Investor NameInvestor SinceParticipating Rounds
Investor 2Jun 2016Series A, Series B
Investor 7Jun 2016Series A
Investor 8Jun 2016Series A

Share Capital

Share Capital

Share allotments and capital structure

36 Allotments 226,091,951 Shares £86.80m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
11 Jan 20261,231,570£123.157£0
11 Jan 202612,090£132.99£0.011
11 Jan 202612,532£835.884£0.067
24 Dec 2025101,976£10.198£0
4 Dec 20254,150,632£415.063£0

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (84)

Pfizer Ventures (us) Llc
7.9%
15,970,639
Merck Ventures B.v
7.9%
15,952,412

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
1 May 2026Confirmation StatementConfirmation statement made on 21 Apr 2026 with updates
27 Apr 2026CapitalAllotment of shares (GBP 27,704.1032) on 10 Apr 2026
20 Apr 2026CapitalAllotment of shares (GBP 27,446.1096) on 10 Apr 2026
31 Mar 2026CapitalAllotment of shares (GBP 24,516.3553) on 19 Mar 2026
5 Feb 2026CapitalAllotment of shares (GBP 24,440.5786) on 11 Jan 2026
1 May 2026 Confirmation Statement

Confirmation statement made on 21 Apr 2026 with updates

27 Apr 2026 Capital

Allotment of shares (GBP 27,704.1032) on 10 Apr 2026

20 Apr 2026 Capital

Allotment of shares (GBP 27,446.1096) on 10 Apr 2026

31 Mar 2026 Capital

Allotment of shares (GBP 24,516.3553) on 19 Mar 2026

5 Feb 2026 Capital

Allotment of shares (GBP 24,440.5786) on 11 Jan 2026

Recent Activity

Latest Activity

Confirmation statement made on 21 Apr 2026 with updates

2 days ago on 1 May 2026

Allotment of shares (GBP 27,704.1032) on 10 Apr 2026

6 days ago on 27 Apr 2026

Allotment of shares (GBP 27,446.1096) on 10 Apr 2026

1 weeks ago on 20 Apr 2026

Allotment of shares (GBP 24,516.3553) on 19 Mar 2026

1 months ago on 31 Mar 2026

Allotment of shares (GBP 24,440.5786) on 11 Jan 2026

2 months ago on 5 Feb 2026